Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DR26FSKE5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,683
Award facts
- Contract value 100% obligated
- $5,682.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,682.96 by the Defense Logistics Agency on November 18, 2025, for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order represents a specific procurement under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a ceiling value of $499.999 billion and a completion date of December 31, 2036. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement.
The delivery order reflects DMS Pharmaceutical Group's established role as a critical pharmaceutical supplier within the Department of Defense's global military healthcare supply chain. As a regional prime vendor under the PPV-G GEN V acquisition strategy—a $30.3 billion initiative—the company is authorized to fulfill diverse pharmaceutical needs for military medical facilities worldwide through firm fixed-price delivery orders covering branded and generic prescription drugs, biologics, and medical consumables. The Nexplanon implant delivery represents routine pharmaceutical distribution activity for this contractor, which has demonstrated substantial federal contracting performance across multiple therapeutic categories and product lines since its registration in the System for Award Management in 2001.
Quick answers
Who was awarded contract SPE2DR26FSKE5?
SPE2DR26FSKE5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FSKE5 worth?
The government has obligated $5,683 on SPE2DR26FSKE5.
Is contract SPE2DR26FSKE5 an order under another contract?
Yes. SPE2DR26FSKE5 is a delivery order under SPE2DR25D9317, an indefinite delivery contract.
Was contract SPE2DR26FSKE5 competed?
The extent of competition for SPE2DR26FSKE5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award